| 1. |
Nagakawa T, Kayahara M, Ikeda S, et al. Biliary tract cancer treatment: results from the Biliary Tract Cancer Statistics Registry in Japan. J Hepatobiliary Pancreat Surg, 2002, 9(5): 569-575.
|
| 2. |
Nishio H, Nagino M, Nimura Y. Surgical management of hilar cholangiocarcinoma: the Nagoya experience. HPB (Oxford), 2005, 7(4): 259-262.
|
| 3. |
董家鸿, 冯晓彬. 精准外科时代的肝门部胆管癌治疗. 中华消化外科杂志, 2019, 18(4): 307-310.
|
| 4. |
董家鸿, 项灿宏, 石军, 等. 以围肝门切除为本的肝门部胆管癌治愈性切除术的临床疗效. 中华消化外科杂志, 2017, 16(10): 1053-1060.
|
| 5. |
Bagante F, Tran T, Spolverato G, et al. Perihilar cholangiocarcinoma: number of nodes examined and optimal lymph node prognostic scheme. J Am Coll Surg, 2016, 222(5): 750-759.
|
| 6. |
李富宇, 程南生, 马文杰. 肝门部胆管癌根治与淋巴结清扫范围. 中国普外基础与临床杂志, 2018, 25(8): 993-996.
|
| 7. |
Greene FL, Page DL, FIeming ID, et al. American Joint Committee on Cancer (AJCC). Cancer Staging Manual. 6th ed. New York: Springer, 2002.
|
| 8. |
Edge S, Byrd D, Compton CC, et al. American Joint Committee on Cancer (AJCC). Cancer Staging Manual. 7th ed. New York: Springer, 2010.
|
| 9. |
Amin MB, Edge S, Greene F, et al. American Joint Committee on Cancer (AJCC). Cancer Staging Manual. 8th ed. New York: Springer, 2017.
|
| 10. |
毛谅, 陈骏, 孙士全, 等. 美国癌症联合委员会肝门部胆管癌分期系统(第8版)更新解读. 中国实用外科杂志, 2017, 37(5): 510-513.
|
| 11. |
Miyazaki M, Ohtsuka M, Miyakawa S, et al. Classification of biliary tract cancers established by the Japanese Society of Hepato-Biliary-Pancreatic Surgery: 3(rd) English edition. J Hepatobiliary Pancreat Sci, 2015, 22(3): 181-196.
|
| 12. |
Kitagawa Y, Nagino M, Kamiya J, et al. Lymph node metastasis from hilar cholangiocarcinoma: audit of 110 patients who underwent regional and paraaortic node dissection. Ann Surg, 2001, 233(3): 385-392.
|
| 13. |
Aoba T, Ebata T, Yokoyama Y, et al. Assessment of nodal status for perihilar cholangiocarcinoma: location, number, or ratio of involved nodes. Ann Surg, 2013, 257(4): 718-725.
|
| 14. |
Giuliante F, Ardito F, Guglielmi A, et al. Association of lymph node status with survival in patients after liver resection for hilar cholangiocarcinoma in an Italian multicenter analysis. JAMA Surg, 2016, 151(10): 916-922.
|
| 15. |
Kambakamba P, Linecker M, Slankamenac K, et al. Lymph node dissection in resectable perihilar cholangiocarcinoma: a systematic review. Am J Surg, 2015, 210(4): 694-701.
|
| 16. |
Ito K, Ito H, Allen PJ, et al. Adequate lymph node assessment for extrahepatic bile duct adenocarcinoma. Ann Surg, 2010, 251(4): 675-681.
|
| 17. |
Mao K, Liu J, Sun J, et al. Patterns and prognostic value of lymph node dissection for resected perihilar cholangiocarcinoma. J Gastroenterol Hepatol, 2016, 31(2): 417-426.
|
| 18. |
Hakeem AR, Marangoni G, Chapman SJ, et al. Does the extent of lymphadenectomy, number of lymph nodes, positive lymph node ratio and neutrophil-lymphocyte ratio impact surgical outcome of perihilar cholangiocarcinoma? Eur J Gastroenterol Hepatol, 2014, 26(9): 1047-1054.
|
| 19. |
Conci S, Ruzzenente A, Sandri M, et al. What is the most accurate lymph node staging method for perihilar cholangiocarcinoma? Comparison of UICC/AJCC pN stage, number of metastatic lymph nodes, lymph node ratio, and log odds of metastatic lymph nodes. Eur J Surg Oncol, 2017, 43(4): 743-750.
|
| 20. |
Guglielmi A, Ruzzenente A, Campagnaro T, et al. Prognostic significance of lymph node ratio after resection of peri-hilar cholangiocarcinoma. HPB (Oxford), 2011, 13(4): 240-245.
|
| 21. |
Kiriyama M, Ebata T, Aoba T, et al. Prognostic impact of lymph node metastasis in distal cholangiocarcinoma. Br J Surg, 2015, 102(4): 399-406.
|
| 22. |
Taniguchi K, Tabata M, Iida T, et al. Significance of lymph node micrometastasis in pN0 hilar bile duct carcinoma. Eur J Surg Oncol, 2006, 32(2): 208-212.
|
| 23. |
Yonemori A, Kondo S, Matsuno Y, et al. Prognostic impact of para-aortic lymph node micrometastasis in patients with regional node-positive biliary cancer. Br J Surg, 2009, 96(5): 509-516.
|
| 24. |
Yonemori A, Kondo S, Matsuno Y, et al. Prognostic impact of regional lymph node micrometastasis in patients with node-negative biliary cancer. Ann Surg, 2010, 252(1): 99-106.
|
| 25. |
Mantel HT, Wiggers JK, Verheij J, et al. Lymph node micrometastases are associated with worse survival in patients with otherwise node-negative hilar cholangiocarcinoma. Ann Surg Oncol, 2015, 22(Suppl 3): S1107-S1115.
|
1/5
WeChat